Although additional support is needed, combined with their apparent mutual exclusivity with mutations in IDH and changes characteristic for IDH-wildtype tumors, these findings indicate that H3 K27M and H3 G34R/V mutations may be glioma initiation events [32]. Here, IDH1 is linked to central nervous system cancer.